Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease-Reference-Cited by-同舟云学术

Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease

Published:2020-04 Issue: Volume:74 Page:92-98
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Campochiaro Corrado,Della-Torre Emanuel,Lanzillotta Marco,Bozzolo Enrica,Baldissera Elena,Milani Raffaella,Arcidiacono Paolo Giorgio,Crippa Stefano,Falconi Massimo,Dagna Lorenzo

Funder

Fondazione Italiana per la Ricerca sull'Artrite (FIRA Onlus)

Giovani Ricercatori Research Grant

Cariplo Foundation

Collegio Ghislieri

Publisher

Elsevier BV

Subject

Internal Medicine

Reference33 articles.

2. An update on IgG4-related lung disease;Morales;Eur J Intern Med,2019

3. IgG4-related disease;Stone;N Engl J Med,2012

5. Treatment approaches to IgG4-related systemic disease;Khosroshahi;Curr Opin Rheumatol,2011

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab in IgG4 Related Disease: A Retrospective Study from a Single Tertiary Care Centre;Indian Journal of Rheumatology;2024-09-04

2. B-cell depletion works in IgG4-related disease. What else?;European Journal of Internal Medicine;2024-09

3. Efficacy and safety of rituximab induction therapy and effect of rituximab maintenance for IgG4-related disease: a systematic review and meta-analysis;European Journal of Internal Medicine;2024-09

4. A case of immunoglobulin G4–related disease complicated by atopic dermatitis responsive to upadacitinib treatment;Modern Rheumatology Case Reports;2024-08-23

5. Fibrotic phenotype of IgG4-related disease;The Lancet Rheumatology;2024-07